ADVERTISEMENT
ADVERTISEMENT

Cancer Genetics

Edited by: Paul Smaglik and Eugene Russo R. Scully, J.J. Chen, A. Plug, Y.H. Xiao, D. Weaver, J. Feunteun, T. Ashley, D.M. Livingston, "Association of BRCA1 with Rad51 in mitotic and meiotic cells," Cell, 88:265-75, Jan. 24, 1997. (Cited in more than 235 papers since publication) Comments by David M. Livingston, Emil Frei professor of genetics and medicine, Harvard Medical School, and chairman of the executive committee for research, Dana-Farber Cancer Institute David M. Livingston The tumo

The Scientist Staff

Edited by: Paul Smaglik and Eugene Russo
R. Scully, J.J. Chen, A. Plug, Y.H. Xiao, D. Weaver, J. Feunteun, T. Ashley, D.M. Livingston, "Association of BRCA1 with Rad51 in mitotic and meiotic cells," Cell, 88:265-75, Jan. 24, 1997. (Cited in more than 235 papers since publication)

Comments by David M. Livingston, Emil Frei professor of genetics and medicine, Harvard Medical School, and chairman of the executive committee for research, Dana-Farber Cancer Institute


David M. Livingston
The tumor-suppressing ability of the infamous BRCA1 gene--which, along with BRCA2, has been linked to breast cancer1,2--was a complete mystery prior to the findings reported in this paper. Some had speculated that the gene's product served as a growth factor or a hormone. Senior author David M. Livingston and his colleagues at Harvard were the first to give some definitive indication as to where the gene might fit into the...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
ADVERTISEMENT